Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector

By Xuan X.   Tuchiya K.   Sato I.   Nishikawa Y.   Onoderaz Y.   Takashima Y.   Yamamoto A.   Katsumata A.   Iwata A.   Ueda S.   Mikami T.   Otsuka H.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 969-976

Elsevier

Access to resources Recommend Favorite

Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection

By Ray N.B.   Ewalt L.C.   Lodmell D.L.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 892-895

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a recombinant lumpy skin disease virus (neethling vaccine strain) expressing the rabies virus glycoprotein in cattle

By Aspden K.   Dijk A.A.v.   Bingham J.   Cox D.   Passmore J.-A.   Williamson A.-L.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2693-2701

Elsevier

Access to resources Recommend Favorite

Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine

By Liangbiao H.   Ngichabe C.   Trimarchi C.V.   Esposito J.J.   Scott F.W.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1466-1472

Elsevier

Access to resources Recommend Favorite

Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies

By Tims T.   Briggs D.J.   Davis R.D.   Moore S.M.   Xiang Z.   Ertl H.C.J.   Fu Z.F.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2804-2807

Elsevier

Access to resources Recommend Favorite